A proof of concept study towards multi‐omics‐based computational drug repositioning in Alzheimer’s disease
Background Alzheimer’s disease (AD) is a devastating neurodegenerative disorder for which there currently are no disease‐modifying treatments available. To accelerate the path to effective intervention strategies, drug repositioning – the application of available compounds in a novel disease context...
Gespeichert in:
Veröffentlicht in: | Alzheimer's & dementia 2021-12, Vol.17, p.e056673-n/a |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!